These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains. Lásaro MO; Luiz WB; Sbrogio-Almeida ME; Nishimura LS; Guth BE; Ferreira LC Infect Immun; 2004 Nov; 72(11):6480-91. PubMed ID: 15501779 [TBL] [Abstract][Full Text] [Related]
4. Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response. Pascual DW; Hone DM; Hall S; van Ginkel FW; Yamamoto M; Walters N; Fujihashi K; Powell RJ; Wu S; Vancott JL; Kiyono H; McGhee JR Infect Immun; 1999 Dec; 67(12):6249-56. PubMed ID: 10569734 [TBL] [Abstract][Full Text] [Related]
6. New vaccine strategies against enterotoxigenic Escherichia coli. II: Enhanced systemic and secreted antibody responses against the CFA/I fimbriae by priming with DNA and boosting with a live recombinant Salmonella vaccine. Lásaro MO; Alves AM; Guillobel HC; Almeida DF; Ferreira LC Braz J Med Biol Res; 1999 Feb; 32(2):241-6. PubMed ID: 10347761 [TBL] [Abstract][Full Text] [Related]
7. Expression of a pilin subunit BfpA of the bundle-forming pilus of enteropathogenic Escherichia coli in an aroA live salmonella vaccine strain. Schriefer A; Maltez JR; Silva N; Stoeckle MY; Barral-Netto M; Riley LW Vaccine; 1999 Feb; 17(7-8):770-8. PubMed ID: 10067682 [TBL] [Abstract][Full Text] [Related]
9. Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae. Tobias J; Lebens M; Bölin I; Wiklund G; Svennerholm AM Vaccine; 2008 Feb; 26(6):743-52. PubMed ID: 18191006 [TBL] [Abstract][Full Text] [Related]
10. Epitope analysis of the CS3 fimbrial subunit of human enterotoxigenic Escherichia coli and the construction of novel CS3::ST and CS3::LT-B immunogens. Yakhchali B; Manning PA Behring Inst Mitt; 1997 Feb; (98):124-34. PubMed ID: 9382733 [TBL] [Abstract][Full Text] [Related]
11. Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli. Noriega FR; Losonsky G; Wang JY; Formal SB; Levine MM Infect Immun; 1996 Jan; 64(1):23-7. PubMed ID: 8557344 [TBL] [Abstract][Full Text] [Related]
12. Characterization of Mucosal Immune Responses to Enterotoxigenic Escherichia coli Vaccine Antigens in a Human Challenge Model: Response Profiles after Primary Infection and Homologous Rechallenge with Strain H10407. Chakraborty S; Harro C; DeNearing B; Ram M; Feller A; Cage A; Bauers N; Bourgeois AL; Walker R; Sack DA Clin Vaccine Immunol; 2016 Jan; 23(1):55-64. PubMed ID: 26581889 [TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of a prototype enterotoxigenic Escherichia coli adhesin vaccine in mice and nonhuman primates. Sincock SA; Hall ER; Woods CM; O'Dowd A; Poole ST; McVeigh AL; Nunez G; Espinoza N; Miller M; Savarino SJ Vaccine; 2016 Jan; 34(2):284-291. PubMed ID: 26597148 [TBL] [Abstract][Full Text] [Related]
15. Stimulation of mucosal immune response following oral administration of enterotoxigenic Escherichia coli fimbriae (CFA/I) entrapped in liposomes in conjunction with inactivated whole-cell Vibrio cholerae vaccine. Dima VF; Ionescu MD; Palade R; Balotescu C; Becheanu G; Dima SV Roum Arch Microbiol Immunol; 2001; 60(1):27-54. PubMed ID: 11850896 [TBL] [Abstract][Full Text] [Related]
16. Salmonella ghosts expressing enterotoxigenic Escherichia coli k88ab, k88ac, k99, and fasa fimbrial antigens induce robust immune responses in a mouse model. Hur J; Kim CS; Eo SK; Park SY; Lee JH Vet Q; 2015; 35(3):125-32. PubMed ID: 25853619 [TBL] [Abstract][Full Text] [Related]
17. Towards a live oral vaccine against enterotoxigenic Escherichia coli of swine. Attridge S; Hackett J; Morona R; Whyte P Vaccine; 1988 Oct; 6(5):387-9. PubMed ID: 3057757 [TBL] [Abstract][Full Text] [Related]
18. Maternal vaccination with a fimbrial tip adhesin and passive protection of neonatal mice against lethal human enterotoxigenic Escherichia coli challenge. Luiz WB; Rodrigues JF; Crabb JH; Savarino SJ; Ferreira LC Infect Immun; 2015 Dec; 83(12):4555-64. PubMed ID: 26371126 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the abilities of Salmonella typhimurium rpoS, aroA and rpoS aroA strains to elicit humoral immune responses in BALB/c mice and to cause lethal infection in athymic BALB/c mice. Coynault C; Norel F Microb Pathog; 1999 Jun; 26(6):299-305. PubMed ID: 10343058 [TBL] [Abstract][Full Text] [Related]
20. Generation of Salmonella ghost cells expressing fimbrial antigens of enterotoxigenic Escherichia coli and evaluation of their antigenicity in a murine model. Kim CS; Hur J; Eo SK; Park SY; Lee JH Can J Vet Res; 2016 Jan; 80(1):40-8. PubMed ID: 26733731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]